Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
16.82
-0.05 (-0.30%)
At close: Jun 18, 2026, 4:00 PM EDT
17.15
+0.33 (1.96%)
After-hours: Jun 18, 2026, 6:05 PM EDT
Jade Biosciences Employees
Jade Biosciences had 55 employees as of December 31, 2025. The number of employees increased by 25 or 83.33% compared to the previous year.
Employees
55
Change
25
Growth
83.33%
Revenue / Employee
n/a
Profits / Employee
-$1,729,036
Market Cap
998.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 25 | 83.33% |
| Dec 31, 2024 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 409 |
| Pharming Group | 407 |
| Xencor | 260 |
| EyePoint | 214 |
| DBV Technologies | 161 |
| ARS Pharmaceuticals | 159 |
| Sana Biotechnology | 142 |
| Lexicon Pharmaceuticals | 81 |
JBIO News
- 3 days ago - Jade Biosciences initiated with a Buy at UBS - TheFly
- 13 days ago - Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 13 days ago - Jade Biosciences Proxy statement: Proxy filing - Filings
- 14 days ago - Jade Biosciences 10M share Secondary priced at $15.00 - TheFly
- 15 days ago - Jade Biosciences Announces Pricing of Public Offering of Common Stock - GlobeNewsWire
- 15 days ago - Jade Biosciences announces common stock offering, no amount given - TheFly
- 15 days ago - Jade Biosciences Announces Proposed Underwritten Public Offering - GlobeNewsWire
- 16 days ago - Jade Biosciences price target raised to $47 from $32 at Guggenheim - TheFly